logo
First look: Most metrics at TFI are down from 2Q 2024 but Bedard touts higher margin

First look: Most metrics at TFI are down from 2Q 2024 but Bedard touts higher margin

Yahoo4 days ago
The earnings report at diversified carrier TFI International (NYSE: TFII) beat Wall Street estimates on the bottom line, but virtually every operational metric in its key LTL division, including the U.S. operations that house the former UPS Freight acquisition, was lower compared to the second quarter of 2024.
But in the first moments of the company's earning call with analysts, CEO Alain Bedard noted 'strong' free cash flow figures and 'solid margin performance.' He also cited sequential improvement in operating ratio at the LTL operations. And Wall Street liked what it heard, with post-close trading boosting TFI stock by about 6.25%.
The operating ratio (OR) at U.S. LTL in the second quarter ballooned to 94% from 90.8% in the corresponding quarter of 2024. Revenue per hundredweight excluding fuel fell just under 2% to $331.18.
In a prepared statement released with the earnings, TFI noted the one bright spot in the U.S. LTL operations, an increase in weight per shipment of just over 5%. But the rest of the countdown of various measures was all negative: a 10.1% drop in the number of shipments and a 5.5% decline in the total level of shipments as measured in tons.
Canadian LTL, which has been the example that TFI management has said it wants to emulate in the U.S., suffered a worse decline in its OR, dropping 500 bps to 80.6%. Revenue per hundredweight excluding fuel was down 3.56%.
The truckload operations at TFI suffered the same sort of weak quarter that has been showing up in other earnings reports from truckload carriers. Revenue before fuel was down about 3.4%, adjusted EBITDA was down a little more, but revenue per truck per week excluding fuel was down only a small amount. The adjusted OR in truckload declined 110 bps to 90.1%.
TFI's overall adjusted net income of $1.34 per share was down from $1.71 in the corresponding quarter a year earlier. However, according to SeekingAlpha, it was still 11 cents better than forecasts.
Total revenue of $1.8 billion was down 9.4% from a year earlier. It was also $20 million less than the Wall Street consensus, according to SeekingAlpha.
By the close of trading Monday, TFI stock was down about 41.3% in the last 12 months before the post-market increase.
,
More articles by John Kingston
Yet another broker liability case, this time in the Fifth Circuit, adds to the growing mix
Ryder's used vehicle numbers show a bullish corner: tractor sales
Five takeaways from the State of Freight for July: What earnings and the indices are saying about the market
The post First look: Most metrics at TFI are down from 2Q 2024 but Bedard touts higher margin appeared first on FreightWaves.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Regeneron shares edge higher as second quarter earnings surpass estimates
Regeneron shares edge higher as second quarter earnings surpass estimates

Yahoo

time26 minutes ago

  • Yahoo

Regeneron shares edge higher as second quarter earnings surpass estimates

-- Regeneron Pharmaceuticals, Inc. reported second-quarter earnings that significantly exceeded analyst expectations, with adjusted earnings per share reaching $12.89 compared to the $8.43 consensus estimate. Revenue also beat forecasts, coming in at $3.68 billion versus the expected $3.28 billion. The biopharmaceutical company's total revenue increased 4% YoY, driven by strong performance across several key products. Dupixent global net sales, recorded by Sanofi (NASDAQ:SNY), grew 22% to $4.34 billion, while EYLEA HD U.S. net sales jumped 29% to $393 million. However, combined EYLEA HD and EYLEA U.S. net sales decreased 25% to $1.15 billion. The stock is up 0.3% following the results. "Regeneron (NASDAQ:REGN) had a strong quarter, marked by significant growth in U.S. sales of EYLEA HD and global sales of Dupixent and Libtayo along with multiple regulatory approvals," said Leonard Schleifer, Chief Executive Officer of Regeneron. The company reported several regulatory achievements during the quarter, including FDA approval for Lynozyfic for relapsed or refractory multiple myeloma and Dupixent approvals for bullous pemphigoid and chronic spontaneous urticaria. The FDA also accepted for priority review Libtayo's application for adjuvant cutaneous squamous cell carcinoma. Regeneron updated its financial guidance for 2025, adjusting its R&D and SG&A expense projections. The company now expects non-GAAP R&D expenses of $5.1-$5.2 billion and non-GAAP SG&A expenses of $2.45-$2.55 billion. During the quarter, Regeneron returned over $2.3 billion to shareholders through share repurchases and dividends. The company's board declared a cash dividend of $0.88 per share, payable on September 3, 2025. Related articles Regeneron shares edge higher as second quarter earnings surpass estimates These Under-the-Radar Stocks Offer Better Risk-Reward Ratio Than Nvidia Apollo economist warns: AI bubble now bigger than 1990s tech mania Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

CDW Names Mukesh Kumar Chief Services and Solutions Officer
CDW Names Mukesh Kumar Chief Services and Solutions Officer

Yahoo

time26 minutes ago

  • Yahoo

CDW Names Mukesh Kumar Chief Services and Solutions Officer

VERNON HILLS, Ill., August 01, 2025--(BUSINESS WIRE)--CDW (Nasdaq: CDW) announced today that Mukesh Kumar will join the company as Chief Services and Solutions Officer on August 4, 2025, reporting to Chair and Chief Executive Officer, Christine A. Leahy. Kumar will lead CDW's services and solutions business, comprised of our Integrated Technology Solutions and Digital Velocity practices. Kumar joins CDW from Slalom Consulting, where he most recently served as president of the multibillion-dollar technology business. Kumar brings to CDW deep technical depth across a broad spectrum of emerging technologies and long-standing experience driving transformative change. At Slalom, Kumar scaled their technology-based services teams across the Americas and led Slalom's technology partner ecosystem of 800+ partnerships, including AWS, Salesforce, Microsoft, and Google. Kumar brings nearly 30 years of technology and consulting leadership and is highly regarded in the technology community for his creative and forward-thinking solutioning and ability to incubate, grow, and scale businesses. "At CDW, our purpose is simple: to make technology work so people can do great things," said Christine A. Leahy, Chair and Chief Executive Officer, CDW. "Our customers trust us as a strategic partner to help them navigate the dynamic and increasingly complex technology ecosystem and achieve their business and mission goals. Our technology services and solutions capabilities are crucial to meeting them where they are in their full-stack and lifecycle journey. Mukesh's experience developing and scaling technology-based services and solutions will be invaluable as CDW continues to aggressively invest in these capabilities." About CDW CDW Corporation (Nasdaq: CDW) is a leading multi-brand provider of information technology solutions to business, government, education and healthcare customers in the United States, the United Kingdom and Canada. A Fortune 500 company and member of the S&P 500 Index, CDW helps its customers to navigate an increasingly complex IT market and maximize return on their technology investments. For more information about CDW, please visit View source version on Contacts Investor Inquiries Steve O'BrienSenior Vice President, Investor Relations(847) 968-0238investorrelations@ Media Inquiries Sara GranackVice President, Corporate Communications(847) 419-7411mediarelations@ 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store